Friday, January 13, 2023 9:13:33 AM
Simplicity with Flaskworks EDEN device.
Interesting points, having studied the Flaskworks patents, hardware, software and overall capability of the Flaskworks EDEN, nothing but genius design and hats off to Shashi Murthy for all his design and development effort. The Flaskworks EDEN device has the capability to increase vaccine production rates by a factor of 10x to 15x over standard manual vaccine processes. The good news is that Flaskworks EDEN device is very adaptive via its hardware and software operational capabilities. In all, extensive testing and analysis has already been conducted and will prove that the Flaskworks EDEN device will support current and future vaccine manufacturing. BTW, the Flaskworks EDEN device is extremely adaptive to be able to address multiple statistical manufacturing issues at a CMMI level-5 performance. Having worked with multiple Regulatory Agencies for over 30+ years, the Flaskworks EDEN device sells itself, and will enable and enhance vaccine production both quantity and quality, IMPO.
Interesting points, having studied the Flaskworks patents, hardware, software and overall capability of the Flaskworks EDEN, nothing but genius design and hats off to Shashi Murthy for all his design and development effort. The Flaskworks EDEN device has the capability to increase vaccine production rates by a factor of 10x to 15x over standard manual vaccine processes. The good news is that Flaskworks EDEN device is very adaptive via its hardware and software operational capabilities. In all, extensive testing and analysis has already been conducted and will prove that the Flaskworks EDEN device will support current and future vaccine manufacturing. BTW, the Flaskworks EDEN device is extremely adaptive to be able to address multiple statistical manufacturing issues at a CMMI level-5 performance. Having worked with multiple Regulatory Agencies for over 30+ years, the Flaskworks EDEN device sells itself, and will enable and enhance vaccine production both quantity and quality, IMPO.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
